Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N X Chin

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
The American Journal of Medicine|April 27, 1987
Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteriaN X Chin, H C Neu
The Journal of Antimicrobial Chemotherapy|February 1, 1987
In-vitro activity of two new quinolone antimicrobial agents, S-25930 and S-25932 compared with that of other agentsH C Neu, N X Chin
Antimicrobial Agents and Chemotherapy|January 1, 1988
Tigemonam, an oral monobactamN X Chin, H C Neu
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
In vitro activity of YTR-830H in combination with beta-lactamase unstable beta-lactamsN X Chin, H C Neu
Antimicrobial Agents and Chemotherapy|May 1, 1988
In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746N X Chin, H C Neu
Antimicrobial Agents and Chemotherapy|April 1, 1987
In vitro activity and beta-lactamase stability of a new monobactam, B0-1165H C Neu, N X Chin
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|August 1, 1985
The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibioticsH C Neu, N X Chin
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1986
Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporinN X Chin, H C Neu
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|October 1, 1987
In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporinN X Chin, H C Neu
Chemotherapy|January 1, 1987
Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter speciesN X Chin, H C Neu
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
The American Journal of Medicine|April 27, 1987
Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteriaN X Chin, H C Neu
The Journal of Antimicrobial Chemotherapy|February 1, 1987
In-vitro activity of two new quinolone antimicrobial agents, S-25930 and S-25932 compared with that of other agentsH C Neu, N X Chin
Antimicrobial Agents and Chemotherapy|January 1, 1988
Tigemonam, an oral monobactamN X Chin, H C Neu
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
In vitro activity of YTR-830H in combination with beta-lactamase unstable beta-lactamsN X Chin, H C Neu
Antimicrobial Agents and Chemotherapy|May 1, 1988
In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746N X Chin, H C Neu
Antimicrobial Agents and Chemotherapy|April 1, 1987
In vitro activity and beta-lactamase stability of a new monobactam, B0-1165H C Neu, N X Chin
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|August 1, 1985
The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibioticsH C Neu, N X Chin
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1986
Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporinN X Chin, H C Neu
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|October 1, 1987
In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporinN X Chin, H C Neu
Chemotherapy|January 1, 1987
Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter speciesN X Chin, H C Neu
Pageof 10